The symptom intensity scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms

Journal of Rheumatology

Volumn 33, Issue 11, 2006, Pages 2291-2299

  Wolfe, Frederick ^a,c   Rasker, Johannes J ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

Fibromyalgia; Outcomes; Rheumatoid arthritis; Symptom Intensity Scale; Symptoms

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DEATH; DEMOGRAPHY; DISEASE SEVERITY; ETHNOLOGY; FATIGUE; FEMALE; FIBROMYALGIA; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCORING SYSTEM; SELF REPORT; SEX DIFFERENCE; SMOKING; SOCIAL ASPECT; SOCIOECONOMICS; SYMPTOM INTENSITY SCALE; SYMPTOMATOLOGY; VISUAL ANALOG SCALE; WORK DISABILITY;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS;

EID: 33751017085     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
2. Crofford LJ, Clauw DJ. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed?. Arthritis Rheum 2002;46:1136-8.
3. Goldenberg DL. Fibromyalgia and related syndromes. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. Philadelphia: Mosby; 2003:701-12.
4. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
5. Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006;54:169-76.
6. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004;31:695-700.
7. Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 2003;30:369-78.
8. Akkasilpa S, Goldman D, Magder LS, Petri M. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus. J Rheumatol 2005;32:48-50.
9. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997;56:268-71.
10. Wallace DJ, Clauw DJ. Fibromyalgia and other central pain syndromes. Philadelphia: Lippincott Williams & Wilkins; 2005.
11. Hazemeijer I, Rasker JJ. Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting. Rheumatology Oxford 2003;42:507-15.
12. Gordon DA. Fibromyalgia - real or imagined? J Rheumatol 2003;30:1665.
13. Croft P, Burt J, Schollum J, Thomas E, Macfarlane G, Silman A. More pain, more tender points: Is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 1996;55:482-5.
14. Croft P, Scholium J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309:696-9.
15. Croft P, Rigby AS, Boswell R, Scholium J, Silman AJ. The prevalence of widespread pain in the general population. J Rheumatol 1993;20:710-3.
16. Macfarlane GJ, McBeth J, Silman AJ. Widespread body pain and mortality: prospective population based study. BMJ 2001;323:662-5.
17. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ. Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology Oxford 2001;40:95-101.
18. Wolfe F, Michaud K, Choi HK, Williams R. Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 2005;32:1875-83.
19. Wolfe F, Michaud K. A brief introduction to the National Data Bank for Rheumatic Diseases. Clin Exp Rheumatol 2005;23:S168-71.
20. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004;116:305-11.
21. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51.
22. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
23. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
24. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
25. Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice, observational studies and clinical trials: The Patient Activity Scale (PAS/PAS-II). J Rheumatol 2005;32:2410-5.
26. Meenan RF, Gertman PM, Mason JH, Dunaif R. The Arthritis Impact Measurement Scales. Arthritis Rheum 1982;25:1048-53.
27. Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey. Med Care 1988;26:724-35.
28. Lin LI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
29. Doody MM, Hayes HM, Bilgrad R. Comparability of national death index plus and standard procedures for determining causes of death in epidemiologic studies. Ann Epidemiol 2001;11:46-50.
30. Edlavitch SA, Baxter J. Comparability of mortality follow-up before and after the National Death Index. Am J Epidemiol 1988;127:1164-78.
31. Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 2004;31:1896-902.
32. Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JMGW, Wiegman O. Fatigue in rheumatoid arthritis: The role of self-efficacy and problematic social support. Br J Rheumatol 1998;37:1042-6.
33. Royston P, Cox NJ. A multivariable scatterplot smoother. Stata Journal 2005;5:405-12.
34. Newson R. Parameters beyond "nonparametric" statistics: Kendall's tau, Somers' D and median differences. Stata Journal 2002;2:45-64.
35. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6.
36. Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res 1997;31:125-31.
37. Clauw DJ, Williams D, Lauerman W, et al. Pain sensitivity as a correlate of clinical status in individuals with chronic low back pain. Spine 1999;24:2035-41.
38. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92.
39. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
40. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570-6.
41. Gran JT. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 2003;17:547-61.
42. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983;10:965-8.